Introducing miRometer-122™
Revolutionary Technology for Reliable Results in Liver Toxicity Testing
miRometer-122™ is a cutting-edge Research Use Only (RUO) kit designed to test for microRNA-122 biomarker, a key indicator of drug-induced liver injury (DILI) and liver toxicity. Our assay leverages the innovative nucleic acid nanorobotics (NANs) platform, providing researchers with unparalleled accuracy and efficiency.
miRometer-122™ is currently being validated with a wide range of clinical samples. We invite principal investigators of clinical trials, biotech R&D scientists, and academic researchers to explore how this advanced detection kit can simplify miR-122 testing and deliver consistent, robust results. Get in touch with us to learn more and join our community of early adopters.
Applications
Biomarker Discovery
Explore the role of miRNA-122 in liver diseases and beyond.
Toxicology Studies
Evaluate the hepatic effects of new compounds with confidence.
Pharmaceutical Research
Monitor liver toxicity in preclinical and clinical trials.
Speak with our Founder
Join Our Community of Early Adopters
Be at the forefront of liver toxicity testing and biomarker discovery. Sign up today to join our waiting list and stay informed about product updates, availability, and exclusive offers. Follow these simple steps to join our community:
- Sign up today to secure your place in line for the miRometer-122™.
- Our team will get in touch with you to discuss your specific research needs and project details.
- Receive notifications and important updates, including data from our clinical studies.
